ICRM
CC icon

Insight Capital Research & Management’s Chemours CC Stock Holding History

Insight Capital Research & Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.22M Buy
+43,951
New +$2.07M 1.26% 30
2017
Q2 		– Sell
-72,506
Closed -$2.79M – 114
2017
Q1 		$2.79M Buy
+72,506
New +$2.18M 1.57% 23

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Insight Capital Research & Management's CC Position: Q3 2017 in Review

Insight Capital Research & Management opened a new position in Chemours (CC) in Q3 2017: 43,951 shares worth $2.22M. The stake represents 1.26% of the portfolio and ranks #30 among its holdings. This is a return to the name: Insight Capital Research & Management previously reported a position in CC as recently as Q1 2017.

Insight Capital Research & Management first reported a position in CC in Q1 2017 and has held it in 2 quarters since. The position peaked at $2.79M in Q1 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

  • Insight Capital Research & Management held 43,951 shares of Chemours worth $2.22M as of Q3 2017.
  • Chemours was a new Insight Capital Research & Management position in Q3 2017.
  • Chemours made up 1.26% of Insight Capital Research & Management's portfolio in Q3 2017, its #30 holding.
  • Insight Capital Research & Management first reported a position in Chemours in Q1 2017 and has held it in 2 quarters since.
  • Insight Capital Research & Management's Chemours position peaked at $2.79M in Q1 2017.
  • 499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.